Provided by Tiger Fintech (Singapore) Pte. Ltd.

MAIA Biotechnology Inc.

2.00
-0.1000-4.76%
Pre-market: 2.030.0300+1.50%08:51 EDT
Volume:209.58K
Turnover:414.43K
Market Cap:59.17M
PE:-1.91
High:2.04
Open:2.02
Low:1.90
Close:2.10
Loading ...
Apr 20, 2023

Major Issues Report

8-K - Current report
Apr 18, 2023

Correspondence

Form CORRESP - Correspondence
Apr 18, 2023

Correspondence

Form CORRESP - Correspondence
Apr 18, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 18, 2023

Major Issues Report

8-K - Current report
Apr 11, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 11, 2023

Major Issues Report

8-K - Current report
Apr 07, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 04, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 24, 2023

Major Issues Report

8-K - Current report
Mar 24, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Major Issues Report

8-K/A [Amend] - Current report
Feb 13, 2023

Major Issues Report

8-K - Current report
Feb 13, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 06, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 06, 2023

Major Issues Report

8-K - Current report